Japan Tissue Engineering Co., Ltd. Reports Non-Consolidated Earnings Results for the Nine Months Ended December 31, 2015; Provides Earnings Guidance for the Full Year March 31, 2016
January 29, 2016 at 10:30 am
Share
Japan Tissue Engineering Co., Ltd. reported non-consolidated earnings results for the nine months ended December 31, 2015. For the period, net sales were JPY 956 million against JPY 846 million a year ago. Operating loss was JPY 727 million against JPY 760 million a year ago. Ordinary income was JPY 716 million against JPY 755 million a year ago. Net income was JPY 719 million against JPY 758 million a year ago. Net loss per share was JPY 17.72 against JPY 20.48 a year ago.
For the full year ending March 31, 2016, the company expects to report sales of JPY 1,734 million, operating loss of JPY 773 million, ordinary loss of JPY 584 million, net loss of JPY 588 million or net income per share of JPY 14.50.
Japan Tissue Engineering Co Ltd is a Japan-based company mainly engaged in regenerative medicine product business, regenerative medicine outsourcing business, and research and development support business. The Company operates through three segments. The Regenerative Medicine Product segment develops regenerative medicine products using tissue engineering, and manufactures and sells the products for medical institutions. The regenerative medicine products include autologous cultured epidermis JACE, and autologous cultured cartilage JACK. The Regenerative Medicine Outsourcing segment provides contract development and manufacturing organization (CDMO) services, contract research organization (CRO) services, consulting services, and contract manufacturing services for specific cell processed products. The Research and Development Support segment manufactures and sells human cultured tissues that apply advanced culture technology accumulated through the development of in-house products.
Japan Tissue Engineering Co., Ltd. Reports Non-Consolidated Earnings Results for the Nine Months Ended December 31, 2015; Provides Earnings Guidance for the Full Year March 31, 2016